Sage Journals: Discover world-class research

Abstract

This postal survey among 174 UK palliative physicians, aimed to assess current practice and perceived problems within the management of venous thromboembolism (VTE) in patients with advanced cancer. The questionnaire was returned by 131 out of 174 (74%) of the doctors surveyed. The most common estimated incidence of patients with VTE was 1-5%. The diagnosis of VTE is usually confirmed by further investigation and in general, outpatients are more likely to be anticoagulated than inpatients. Problems with anticoagulation include bleeding, international normalized ratio instability, appropriateness of anticoagulation, practical difficulties associated with monitoring, and recurrent VTE. Although probably less effective, 77 out of 128 (60%) of respondents use subtherapeutic regimes in order to minimize the risks. Patients with advanced malignancy and VTE are anticoagulated, if considered appropriate, by the vast majority of palliative physicians in the UK. Warfarin has been abandoned in favour of low-molecular-weight heparin (LMWH) by 26%. LMWH provides anticoagulation with no need for monitoring, has no significant drug interactions and is not affected by liver dysfunction. Theoretically, LMWH is more effective than warfarin in the secondary prevention of VTE with less risk of bleeding.

Keywords

anticoagulants heparin low-molecular-weight neoplasms questionnaires thromboembolism

Get full access to this article

View all access options for this article.

References

Trousseau A. Lectures on clinical medicine, delivered at the Hotel Dieu, Paris. Translated from the 1968 edition by Cormack London. The New Sydenham Society 1872; 5: 287.

Nand S. , Fisher SG , Salgia R. , Fisher RI Haemostatic abnormalities in untreated cancer. Incidence and correlation with thrombotic and haemorrhagic complications. J Clin Oncol 1987; 5: 1998-2003.

Sandler DA , Martin JF

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thromboses?

J R Soc Med 1989; 82:203-205.

Huisman MV , Buller HR , ten Cate JW et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 496-502.

Sproul EE Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 566-85.

Ambrus JL , Ambrus CM , Pickren JW Causes of death in cancer patients. J Med 1975; 6: 61-64.

Bergentz S-E. Incidence of thromboembolism in association with surgical and medical diseases. Acta Chir Scand 1988; (suppl 543): 10-14.

Morrell MT , Dunnill MS The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55: 347-52.

Sarasin FP , Eckman MH Management and prevention of thromboembolic events in patients with cancer related hypercoagulable states: a risky business. J Gen Intern Med 1993: 8: 476-86.

10.

Gitter MJ , Jaeger TM , Petterson TM et al. Bleeding and thromboembolism during anticoagulant therapy: a population based study at Rochester, Minnesota. Mayo Clin Proc 1995; 70: 725-33.

11.

Colman RW , Rubin RN Disseminated intravascular coagulation due to malignancy. Sem Oncol 1990; 17: 172-86.

12.

Stone DH How to do it: design a questionnaire. Br Med J 1993; 307: 1264-66.

13.

Krauth D. , Holden A. , Knapic N. et al. Safety and efficacy of long-term oral anticoagulation in cancer patients. Cancer 1987; 59: 983-85.

14.

Errichetti AM , Holden A. , Ansell J. Management of oral anticoagulant therapy: Experience with an anticoagulant clinic. Arch Intern Med 1984; 144: 1966-68.

15.

Leizorovic A. , Simmoneau G. , Decousus H. , Boissel JP Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis: a meta-analysis. Br Med J 1994; 309: 299-304.

16.

Teo CP , Lim HL , Kueh YK Cost-effectiveness and ease of administration of low molecular weight heparin in deep venous thrombosis. Thromb Haemost 1994; 92: 328-29.

17.

Nurmohamed M. , Rosendaal F. , Buller H. et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-56.

18.

Leizorovicz A. , Haugh MC , Chapuis FR Samama MM , Boisch JP Low molecular weight heparin in prevention of peri-operative thrombosis. Br Med J 1992 ;305:13-20.

How do palliative physicians manage venous thromboembolism?

Abstract

Keywords

Get full access to this article

References